We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence (PRO-810)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00768482
Recruitment Status : Terminated (This study was terminated for reasons not related to efficacy or safety)
First Posted : October 8, 2008
Last Update Posted : June 14, 2017
Information provided by (Responsible Party):
Braeburn Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2008
  Study Completion Date : December 2008
  Certification or Request for Extension to Delay Results Submission: January 5, 2011